An interventional study of care management in Depression, Elderly and Korean, sponsored by National Clinical Research Coordination Center, Seoul, Korea. Completed at 1 site in Korea, Republic of. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2016-03-11.
Sponsored by National Clinical Research Coordination Center, Seoul, Korea · Not applicable, Interventional, and Treatment
Late-life depression is associated with physical limitations, greater functional impairment, increased utilization and cost of health care, and suicide. Collaborative care, linking primary and mental health specialty care, has been shown to be effective for the treatment of late-life depression in primary care settings in Western countries. The primary aim of this project is to implement a depression care management intervention, and examine its effectiveness on the depressive symptoms of older patients in Korean primary care settings. Based on chronic disease management theory and previous Collaborative care management studies in western countries, we propose to test a Depression Care Management intervention,which includes care manager to support a primary care physician of depression in their old patients. Care manager'd role are monitoring the progress of treatment, supporting patient's adherence, educating patients/ family and facilitate communication between providers. Also psychiatrists provide consultation and supervision of care managers. Using a randomized controlled design, we will examine whether the Depression care management is an effective treatment for patients with late life depression in rural Korea. The primary outcome would be the improvement of depressive symptoms of patients in primary care setting.
8,057 studies on the registry are indexed under Depression; 1,643 are open to participants now.
This study's enrollment of 80 is close to the median of 84 across 6,718 interventional studies indexed under Depression.
Browse Depression studies →National Clinical Research Coordination Center, Seoul, Korea is the lead sponsor of 5 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
patients who assigned to the intervention group will take 7 times phone calls from case manager
Other: care management
usual care
patients who assigned to the intervention group will take 7 times phone calls from case manager
Reduced depression symptoms
HAMD (Hamilton Depression Ratind Scale) Difference HAMD score between the intervention and control group from baseline to 3 month follow-up
Time frame: 3 months
Depression response and remissionhealth related quality of life
HAMD (Hamilton Depression Ratind Scale) Depression response is defined by improvement 50% or more HAMD scores from baseline to each follow-up periods. Depression remission is defined by 7 or less of HAMD score at each follow-up periods
Time frame: 3months and 6months
Reduced suicide ideation
SSI (Beck's suicide ieation scale) Difference total SSI scores Between the two groups from baseline to each follow-up periods
Time frame: 3 months and 6 months
Improvement of Quality of life
EQ5D Difference EQ5D scores Between the two groups from baseline to each follow-up periods
Time frame: 3 months and 6 months
This study is completed, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Clinical Research Coordination Center, Seoul, Korea